Bruce G. Allen Investments, LLC Novartis Ag Transaction History
Bruce G. Allen Investments, LLC
- $119 Billion
- Q2 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 2,524 shares of NVS stock, worth $294,020. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,524
Previous 2,816
10.37%
Holding current value
$294,020
Previous $272 Million
1.35%
% of portfolio
0.23%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$864 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$863 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$693 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...